Strategy Holding Ltd Wealth serves as Executive at CASI Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Strategy Holding Ltd Wealth has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 30, 2019 involved exercising options for 493,827 shares valued at $834.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 30, 2019 | CASI | $834.6K | Exercise | 493,827 | $1.69 | Discretionary |
Strategy Holding Ltd Wealth currently holds 9,087,888 shares of CASI Pharmaceuticals, Inc. (CASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Strategy Holding Ltd Wealth has been a net neutral trader of CASI stock. They have purchased $0 and sold $0 worth of shares.
Strategy Holding Ltd Wealth's most recent insider trade was on Dec 30, 2019, when they sold 493,827 shares at $1.69 per share.
Get notified when new Form 4 filings are submitted